Furthermore, ATF6α-mediated activation of Rheb and mTOR signalling promotes survival of dormant human squamous carcinoma cells (D-HEp3 cells) and their adaptation to chemotherapy and the in vivo microenvironment [47]. Here, ATF6 is linked to squamous cell carcinoma.